CenterWatch

Neutropenia Clinical Trials

A listing of Neutropenia medical research trials actively recruiting patient volunteers. Use the filters below to narrow your search results.

Filter By:

 

California

La Jolla California 92093

Patients are needed to participate in a clinical research study of CLT-008 and G-CSF to evaluate Acute Myeloid Leukemia

Illinois

Chicago Illinois 60611

Patients are needed to participate in a clinical research study of CLT-008 and G-CSF to evaluate Acute Myeloid Leukemia

Indiana

Indianapolis Indiana 46237

Patients are needed to participate in a clinical research study of CLT-008 and G-CSF to evaluate Acute Myeloid Leukemia

Maryland

Bethesda Maryland 20892

Patients are needed to participate in a clinical research study of Clofarabine and Lenalidomide

New York

New York New York 10065

A Phase 4 clinical study for patients with Acute Myelogenous Leukemia or Myelodysplastic Syndrome

Pennsylvania

Pittsburgh Pennsylvania 15224

Patients are needed to participate in a clinical research study of CLT-008 and G-CSF to evaluate Acute Myeloid Leukemia

Texas

Houston Texas 77030

Patients are needed to participate in a clinical research study of CLT-008 and G-CSF to evaluate Acute Myeloid Leukemia

Austria

Eggenburg 3730

A clinical study for patients with Chemotherapy-induced Febrile Neutropenia

Leoben 8700

A clinical study for patients with Chemotherapy-induced Febrile Neutropenia

Wien 1030

A clinical study for patients with Chemotherapy-induced Febrile Neutropenia

Wien 1090

A clinical study for patients with Chemotherapy-induced Febrile Neutropenia

Belgium

Arlon 6700

A clinical study for patients with Chemotherapy-induced Febrile Neutropenia

Liège 4000

A clinical study for patients with Chemotherapy-induced Febrile Neutropenia

China

Beijing

A clinical research study of pegfilgrastim,30mcg/kg, pegfilgrastim, 60mcg/kg, pegfilgrastim, 100mcg/kg and filgrastim, 5mcg/kg for the treatment of Neutropenia

Beijing Beijing 100021

Patients are needed to participate in a clinical research study evaluating Pegfilgrastim for the treatment of Neutropenia

Beijing 100142

Patients are needed to participate in a clinical research study of rHSA/GCSF to evaluate Underdose (Unintentional), Cancer or Tumor

Beijing

Safety and Efficacy of YPEG-rhG-CSF in Cancer Patients Receiving Chemotherapy for the treatment of Non Small Cell Lung Cancer or Breast Cancer

Fuzhou

Safety and Efficacy of YPEG-rhG-CSF in Cancer Patients Receiving Chemotherapy for the treatment of Non Small Cell Lung Cancer or Breast Cancer

View More ▼

Fuzhou

Safety and Efficacy of YPEG-rhG-CSF in Cancer Patients Receiving Chemotherapy for the treatment of Non Small Cell Lung Cancer or Breast Cancer

Fuzhou

Safety and Efficacy of YPEG-rhG-CSF in Cancer Patients Receiving Chemotherapy for the treatment of Non Small Cell Lung Cancer or Breast Cancer

Guangzhou

Safety and Efficacy of YPEG-rhG-CSF in Cancer Patients Receiving Chemotherapy for the treatment of Non Small Cell Lung Cancer or Breast Cancer

Shanghai Shanghai 200433

A Phase 3 clinical study for patients with NSCLC, Neutropenia or Febrile Neutropenia

Shanghai

Safety and Efficacy of YPEG-rhG-CSF in Cancer Patients Receiving Chemotherapy for the treatment of Non Small Cell Lung Cancer or Breast Cancer

Shanghai

Safety and Efficacy of YPEG-rhG-CSF in Cancer Patients Receiving Chemotherapy for the treatment of Non Small Cell Lung Cancer or Breast Cancer

Tianjin Tianjin 300060

Patients are needed to participate in a clinical research study evaluating GW003 for the treatment of Chemotherapy-induced Neutropenia or Metastatic Tumors

Wuhan

Safety and Efficacy of YPEG-rhG-CSF in Cancer Patients Receiving Chemotherapy for the treatment of Non Small Cell Lung Cancer or Breast Cancer

Xiamen

Safety and Efficacy of YPEG-rhG-CSF in Cancer Patients Receiving Chemotherapy for the treatment of Non Small Cell Lung Cancer or Breast Cancer

Zhejiang

Safety and Efficacy of YPEG-rhG-CSF in Cancer Patients Receiving Chemotherapy for the treatment of Non Small Cell Lung Cancer or Breast Cancer

Czech Republic

Chomutov 430 12

A clinical study for patients with Chemotherapy-induced Febrile Neutropenia

Horovice 268 31

A clinical study for patients with Chemotherapy-induced Febrile Neutropenia

Novy Jicin 741 01

A clinical study for patients with Chemotherapy-induced Febrile Neutropenia

Plzen 304 60

A clinical study for patients with Chemotherapy-induced Febrile Neutropenia

Praha 10 100 34

A clinical study for patients with Chemotherapy-induced Febrile Neutropenia

View More ▼

Praha 2 128 08

A clinical study for patients with Chemotherapy-induced Febrile Neutropenia

France

Aix en Provence 13100

A clinical study for patients with Chemotherapy-induced Febrile Neutropenia

Beuvry 62660

A clinical study for patients with Chemotherapy-induced Febrile Neutropenia

Marseille 13009

A clinical study for patients with Chemotherapy-induced Febrile Neutropenia

Meaux Cedex 77100

A clinical study for patients with Chemotherapy-induced Febrile Neutropenia

Nancy 54100

A clinical study for patients with Chemotherapy-induced Febrile Neutropenia

View More ▼

Nimes Cedex 2 30900

A clinical study for patients with Chemotherapy-induced Febrile Neutropenia

Orleans Cedex 45067

A clinical study for patients with Chemotherapy-induced Febrile Neutropenia

Paris 75015

A clinical research study of 18F-FDG PET Scan

Périgueux cedex 24004

A clinical study for patients with Chemotherapy-induced Febrile Neutropenia

Perpignan 66000

A clinical study for patients with Chemotherapy-induced Febrile Neutropenia

Pierre Benite Cedex 69495

A clinical study for patients with Chemotherapy-induced Febrile Neutropenia

Sarcelles 95200

A clinical study for patients with Chemotherapy-induced Febrile Neutropenia

Strasbourg 67000

A clinical study for patients with Chemotherapy-induced Febrile Neutropenia

Germany

Aurich

Patients are needed to participate in a clinical research study evaluating lipegfilgrastim and pegfilgrastim for the treatment of Aggressive B Cell Non-Hodgkin Lymphomas at High Risk for R-CHOP-21-induced Neutropenia

Bad Soden

Patients are needed to participate in a clinical research study evaluating lipegfilgrastim and pegfilgrastim for the treatment of Aggressive B Cell Non-Hodgkin Lymphomas at High Risk for R-CHOP-21-induced Neutropenia

Berlin

Patients are needed to participate in a clinical research study evaluating lipegfilgrastim and pegfilgrastim for the treatment of Aggressive B Cell Non-Hodgkin Lymphomas at High Risk for R-CHOP-21-induced Neutropenia